MedTrace Logo

Expiratory and Plasma Propofol Concentration in Gastrological Surgery Patients

NCT03817541 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-02-05

No results posted yet for this study

Summary

Determination of accuracy With Edmond (reg) expiratory propofol measurement Device, compared With concommitant plasma samples of propofol

Conditions

  • Bariatric Surgery Candidate
  • Cholecystectomy

Interventions

DEVICE

Edmon (reg), BBraun

exhaled propofol will be compared With plasma propofol values

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-14
Primary Completion
2019-06-30
Completion
2020-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03817541 on ClinicalTrials.gov